Scher HI - Search Results

1

Genomic correlates of clinical outcome in advanced prostate cancer.

Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, Cieslik M, Benelli M, Robinson D, Van Allen EM, Sboner A, Fedrizzi T, Mosquera JM, Robinson BD, De Sarkar N, Kunju LP, Tomlins S, Wu YM, Nava Rodrigues D, Loda M, Gopalan A, Reuter VE, Pritchard CC, Mateo J, Bianchini D, Miranda S, Carreira S, Rescigno P, Filipenko J, Vinson J, Montgomery RB, Beltran H, Heath EI, Scher HI, Kantoff PW, Taplin ME, Schultz N, deBono JS, Demichelis F, Nelson PS, Rubin MA, Chinnaiyan AM, Sawyers CL. Abida W, et al. Among authors: scher hi. Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi: 10.1073/pnas.1902651116. Epub 2019 May 6. Proc Natl Acad Sci U S A. 2019. PMID: 31061129 Free PMC article.

2

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.

Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Among authors: scher hi. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.

3

Chemotherapy for muscle-infiltrating bladder cancer.

Scher HI, Kantoff PW. Scher HI, et al. Hematol Oncol Clin North Am. 1992 Feb;6(1):169-78. Hematol Oncol Clin North Am. 1992. PMID: 1556048 Review.

4

Chemotherapy for metastatic bladder cancer.

Kantoff PW, Scher HI. Kantoff PW, et al. Among authors: scher hi. Hematol Oncol Clin North Am. 1992 Feb;6(1):195-203. Hematol Oncol Clin North Am. 1992. PMID: 1556050 Review.

5

Prostatic cancer: where do we go from here?

Scher H. Scher H. Curr Opin Oncol. 1991 Jun;3(3):568-74. Curr Opin Oncol. 1991. PMID: 1892925 Review.

6

Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin.

Schultz PK, Kelly WK, Begg C, Liebertz C, Cohen L, Scher HI. Schultz PK, et al. Among authors: scher hi. Urology. 1994 Aug;44(2):237-42. doi: 10.1016/s0090-4295(94)80138-x. Urology. 1994. PMID: 7519382 Free article. Clinical Trial.

7

Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma.

Miller VA, Reuter V, Scher HI. Miller VA, et al. Among authors: scher hi. Urology. 1995 Jul;46(1):111-3. doi: 10.1016/S0090-4295(99)80174-5. Urology. 1995. PMID: 7541581

8

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.

Sarkis AS, Bajorin DF, Reuter VE, Herr HW, Netto G, Zhang ZF, Schultz PK, Cordon-Cardo C, Scher HI. Sarkis AS, et al. Among authors: scher hi. J Clin Oncol. 1995 Jun;13(6):1384-90. doi: 10.1200/JCO.1995.13.6.1384. J Clin Oncol. 1995. PMID: 7751883

9

P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladder.

Petrylak DP, Scher HI, Reuter V, O'Brien JP, Cordon-Cardo C. Petrylak DP, et al. Among authors: scher hi. Ann Oncol. 1994 Nov;5(9):835-40. doi: 10.1093/oxfordjournals.annonc.a059013. Ann Oncol. 1994. PMID: 7848886 Free article.

10

Introduction: prostate cancer.

Scher HI. Scher HI. Semin Oncol. 1994 Oct;21(5):511-3. Semin Oncol. 1994. PMID: 7939744 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

687 results

Search Page